A. Vialichka

Statistics

Publications

Citations

222

H-Index

Active since

2019

Affiliations

University of Illinois Chicago(Current)

JMI Laboratories

University of Illinois Chicago, Rockford campus

A. Vialichka is an author at University of Illinois Chicago specializing in antimicrobial resistance, antibiotic resistance, and medical microbiology.

Publications per year

2019–2022

Publications

Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole

Mark Biagi, X. Tan, Tian-Shung Wu et al. · Journal of Clinical Microbiology · 2019 · 60 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +16

Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia

Mark Biagi, A. Vialichka, M. Jurkovic et al. · Antimicrobial Agents and Chemotherapy · 2020 · 58 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia

Mark Biagi, D. Lamm, K. Meyer et al. · Antimicrobial Agents and Chemotherapy · 2020 · 46 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer

Ratika Kunder, Michelle Velyunskiy, Sara F. Dunne et al. · Cell chemical biology · 2021 · 22 citations · Full text

Medicine, Molecular Biology, Oncology +17

Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens

Mark Biagi, Aisha Shajee, A. Vialichka et al. · Antimicrobial Agents and Chemotherapy · 2020 · 19 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

1–5 of 6